Purpose: This study investigated the prognostic performance of the systemic immune-
inflammation index (SII) in patients with epithelial ovarian cancer (EOC) in Lagos, Nigeria …

Background Inflammation is pathognomonic of all stages of tumor formation, and therefore,
there is renewed interest in systemic inflammatory response (SIR) markers including …

Background To improve the overall survival of epithelial ovarian cancer (EOC) patients, a
more precise risk identification after completion of standard treatment will enhance patients' …

In a growing number of social and clinical scenarios, machine learning (ML) is emerging as
a promising tool for implementing complex multi-parametric decision-making algorithms …

Background Epithelial ovarian cancer (EOC) is a major contributor to cancer-related illness
and death among women worldwide. Obesity, a prevalent condition in many populations …

Background Several studies have shown that whether complete tumor resection can be
achieved during debulking surgery depends on various patient-related factors. However …

Background: The timing of recurrence of epithelial ovarian cancer (EOC) after a standard
primary treatment is an important indicator of the degree of response of the tumour to …

Introduction: This study evaluated systemic immune-inflammatory indices (SIII) among
patients with epithelial ovarian cancer (EOC) to identify affordable markers for disease …

Objective Ovarian cancer in Black women is common in many West African countries but is
relatively rare in North America. Black women have worse survival outcomes when …

Background: Recurrence is common after surgery for epithelial ovarian cancer and is
multifactorial. Perioperative factors affecting stress and inflammation have an influence on …